express delivery
Express delivery to
Select Pincode
Search for Medicine and Healthcare items
Search
Molecule icon

Fludarabine

SHARE

Molecule Summary

Uses
Chronic Lymphocytic Leukaemia
Therapy
Anti-Neoplastic
Side Effects
Low Blood Counts, Infections, Fever, Nausea
3 Step Quality
Assurance
Cash on delivery
available
NPPA
Regulated

Molecule Description

Fludarabine is a prescription anticancer medicine belonging to a group of chemotherapy medicines called antimetabolites. It is mainly used to treat B-cell chronic lymphocytic leukaemia (CLL), including in patients whose cancer has not responded to or has worsened after previous treatment. Fludarabine works by interfering with DNA production, which prevents rapidly growing cancer cells from multiplying and can ultimately cause them to die The medicine is supplied as a solution or powder in vials and must be prepared and diluted by a trained healthcare professional before use. It is given intravenously (into a vein) under the supervision of a specialist doctor. Regular blood tests and medical monitoring are required during treatment to check blood cell counts and monitor for infections, nervous-system problems, and other serious side effects. Fludarabine is a prescription-only medicine and should be used strictly under medical supervision. The treatment plan is decided by the treating doctor based on the condition being treated, your body response and the other medicines you are receiving. Do not change, stop or repeat a dose on your own. Before starting Fludarabine, tell your doctor about all your existing medical conditions, especially heart, liver or kidney problems, and about every medicine, vitamin, supplement and herbal product you take. Tell your doctor if you are pregnant, planning a pregnancy or breastfeeding. Regular blood tests and clinical check-ups are usually needed during treatment so that side effects are picked up early.

Uses

  • Fludarabine is used to treat B-cell chronic lymphocytic leukaemia (CLL), particularly in patients with advanced disease or when previous treatment with standard medicines has not worked

Contraindications

When should one not use Fludarabine

  • If you have a severe allergy to fludarabine or any of its ingredients.

Side effects

Common side effects of this drug are:

  • Bone marrow suppression leading to neutropenia (low white blood cell count), anemia, and thrombocytopenia (low platelet count)
  • Severe immunosuppression and increased susceptibility to opportunistic infections
  • Nausea, vomiting, diarrhea, and loss of appetite
  • Fatigue, asthenia (weakness), and fever
  • Cough and upper respiratory tract infections
  • Peripheral neuropathy (numbness, tingling, or weakness in the extremities)
  • Edema, skin rash, and stomatitis (mouth sores)
  • Visual disturbances
  • Elevated liver enzymes and kidney function changes
  • Severe, life-threatening opportunistic infections
  • Autoimmune hemolytic anemia (AIHA) or other autoimmune cytopenias
  • Severe neurotoxicity (including confusion, agitation, seizures, peripheral neuropathy, coma, or blindness)
  • Tumor lysis syndrome (metabolic imbalances due to rapid cancer cell breakdown)
  • Secondary malignancies (long-term risk)

Precautions and Warnings

Pregnancy

Pregnancy

Fludarabine can cause fetal harm and should generally not be used during pregnancy unless the potential benefit clearly outweighs the risk. Women who can become pregnant and men with partners who can become pregnant should use effective contraception as advised by their doctor.

Breast Feeding

Breast Feeding

Breastfeeding should not be undertaken during treatment with Fludarabine because of the potential for serious adverse effects in the nursing infant

Driving

Driving

Use caution. Fludarabine can cause side effects such as severe fatigue, confusion, weakness, or visual disturbances that may impair your alertness. Avoid driving or operating machinery if you feel unwell following treatment.

Alcohol

Alcohol

There is no specific established alcohol interaction with fludarabine. However, alcohol may worsen fatigue, dizziness, or other treatment-related symptoms. Discuss alcohol consumption with your doctor. r.

Other General Warnings

Other General Warnings

Talk to your doctor if
  • You experience a fever, chills, or any signs of an infection, as prompt medical evaluation is critical due to suppressed immunity.
  • You notice unusual pale skin, extreme fatigue, or dark urine, which can be signs of autoimmune hemolytic anemia.
  • You develop neurological changes, such as confusion, agitation, weakness, or vision loss.
  • You require a blood transfusion, as any blood products given during or after fludarabine therapy must be irradiated to prevent transfusion-associated graft-versus-host disease.
  • If you need a blood transfusion: Tell your doctor that you are receiving fludarabine, as irradiated blood products may be required during and after treatment to reduce the risk of a serious transfusion-related complication.
  • If you have kidney problems: Tell your doctor, as kidney function affects how fludarabine is removed from the body removes fludarabine and your treatment may need to be adjusted.
  • Keep all scheduled blood test appointments so your doctor can monitor your blood cell counts.
  • Report fever, chills, persistent cough, or other signs of infection immediately, as fludarabine can weaken the immune system.
  • Tell your doctor if you notice unusual bruising, tiny red spots on the skin, or bleeding, which may indicate a low platelet count.
  • Report confusion, severe headache, vision changes, numbness, or other new neurological symptoms immediately.
  • Tell all your healthcare providers that you are receiving fludarabine before any medical procedure or blood transfusion, as special blood products may be required during and after treatment.
  • Keep out of the reach of children and pets in a secure medical environment.
  • Clinical staff manage proper disposal of vials, infusion bags, and administration equipment following hospital biomedical waste protocols.

Mode of Action

How Does It Work?

Fludarabine is converted in the body into an active form that interferes with DNA production. It blocks key enzymes cancer cells need to copy and repair their DNA. This prevents abnormal lymphocytes from growing and multiplying, eventually causing these cancer cells to die.

Interactions

Interactions with other medicines

  • Avoid or discuss live vaccines with your doctor during and after treatment, as your severely suppressed immune system can increase the risk of serious infections.
  • Concurrent use with pentostatin is not recommended because of the risk of severe and potentially fatal pulmonary toxicity.
  • Tell your doctor about all prescription medicines, over-the-counter medicines, vitamins, and herbal supplements you take, especially medicines that weaken the immune system or reduce blood cell counts.

Interactions with food items

Maintain a well-balanced diet and drink plenty of fluids (especially water) as directed by your medical care team.

Dosage

Overdose

If an overdose is suspected, seek emergency medical care immediately. The hospital provides treatment, which may include supportive care and close monitoring.

Missed a Dose

If you miss a scheduled infusion or injection appointment, contact your hospital or oncology clinic immediately to reschedule. Do not try to make up a missed session on your own, as your doctor will safely adjust your treatment schedule based on your blood counts and clinical recovery status.

Frequently Asked Questions (FAQs)

Fludarabine can weaken the immune system for a long time. If you receive non-irradiated blood, donor immune cells may attack your body's tissues, causing a serious and potentially life-threatening reaction called transfusion-associated graft-versus-host disease. Irradiated blood products help prevent this complication.

Immune suppression can persist after your treatment course ends. Your doctor will continue to monitor your blood counts and may prescribe medications to prevent opportunistic infections during this recovery window.

AIHA is a serious condition where your immune system mistakenly attacks your own red blood cells, leading to rapid destruction and severe anemia. It is a known potential complication associated with fludarabine therapy, particularly in patients with chronic lymphocytic leukemia.

Avoid live vaccines during and after fludarabine treatment. Ask your doctor before receiving any vaccine, as your immune response may be reduced during treatment.

Severe neurotoxicity is a serious risk, especially at higher doses or in older adults. Contact your oncology team immediately if you experience sudden confusion, agitation, weakness, or vision changes.

Articles

View All

References:

Explore More at Pharmeasy

Why trust PharmEasy?

# ONE OF INDIA'S MOST TRUSTED HEALTHCARE PLATFORM

Leaf
CODAvailable
leaf
Leaf
100%Genuine Medicine
leaf
Leaf
30 DAYReturn Policy
leaf
heartHandMaking medicines affordable, authentic, and easily accessible across India
100% Genuine & verified medicines700+100% Genuine & verified medicines
Medicine orders everyday70,000+Medicine orders everyday
Total customer served70 MillionTotal customer served
Delivery hubs & fulfillment centre70 MillionDelivery hubs & fulfillment centre
Trained & trusted delivery partners7000Trained & trusted delivery partners
Our Payment Partners
https://assets.pharmeasy.in/web-assets/_next/icons/gpay.svghttps://assets.pharmeasy.in/web-assets/_next/icons/paytm.svghttps://assets.pharmeasy.in/web-assets/_next/icons/amazon-pay.svghttps://assets.pharmeasy.in/web-assets/_next/icons/phonepe.svghttps://assets.pharmeasy.in/web-assets/_next/icons/mobikwik.svghttps://assets.pharmeasy.in/web-assets/_next/icons/airtel-money.svghttps://assets.pharmeasy.in/web-assets/_next/icons/ola-money.svghttps://assets.pharmeasy.in/web-assets/_next/icons/maestro.svghttps://assets.pharmeasy.in/web-assets/_next/icons/mastercard.svghttps://assets.pharmeasy.in/web-assets/_next/icons/visa.svghttps://assets.pharmeasy.in/web-assets/_next/icons/rupay.svghttps://assets.pharmeasy.in/web-assets/_next/icons/diners.svg